| Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer’s disease JM Taylor, Z Moore, MR Minter, PJ Crack Journal of Neural Transmission 125, 797-807, 2018 | 80 | 2018 |
| Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotype MR Minter, Z Moore, M Zhang, KM Brody, NC Jones, SR Shultz, JM Taylor, ... Acta neuropathologica communications 4, 1-23, 2016 | 74 | 2016 |
| Abrogation of type-I interferon signalling alters the microglial response to Aβ1–42 Z Moore, F Mobilio, FR Walker, JM Taylor, PJ Crack Scientific Reports 10 (1), 3153, 2020 | 29 | 2020 |
| The involvement of microglia in Alzheimer's disease: a new dog in the fight Z Moore, JM Taylor, PJ Crack British Journal of Pharmacology 176 (18), 3533-3543, 2019 | 28 | 2019 |
| An altered glial phenotype in the NL3R451C mouse model of autism SM Matta, Z Moore, FR Walker, EL Hill-Yardin, PJ Crack Scientific Reports 10 (1), 14492, 2020 | 23 | 2020 |
| Pharmacological inhibition of STING reduces neuroinflammation‐mediated damage post‐traumatic brain injury AL Fryer, A Abdullah, F Mobilio, A Jobling, Z Moore, M de Veer, G Zheng, ... British Journal of Pharmacology, 2023 | 1 | 2023 |
| Deletion of IFNAR1 in APPSWE/PS1 Delta E9 mice results in increased cognitive function and changed microglial phenotype P Crack, M Minter, Z Moore, M Zhang, N Jones, S Shultz, J Taylor JOURNAL OF NEUROCHEMISTRY 134, 120-121, 2015 | | 2015 |
